Acadian Asset Management LLC Cytom X Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $34.5 Billion
- Q4 2024
A detailed history of Acadian Asset Management LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,137,046 shares of CTMX stock, worth $2.57 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,137,046
Previous 3,100,994
1.16%
Holding current value
$2.57 Million
Previous $3.66 Million
11.71%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding CTMX
# of Institutions
71Shares Held
46.1MCall Options Held
3.7KPut Options Held
4.7K-
Tang Capital Management LLC San Diego, CA7.31MShares$6 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.29 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$4.23 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$3.2 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$2.64 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $54.1M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...